PATENT CLAIM ANALYSIS

Application Number: 16020346
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-06
Patent Classification: ["424", "009300"]

Abstract:
Provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for tau are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for tau targeted immunotherapy and diagnosis, respectively.

Claim (Index 54):
The expression vector of  claim 53 , wherein the polypeptide comprises:\n an immunoglobulin heavy chain or fragment thereof comprising a VH with the amino acid sequence set forth in any one of SEQ ID NO: 44 or 45; or an immunoglobulin light chain or fragment thereof comprising a VL with the amino acid sequence set forth in any one of SEQ ID NO:46, 221, or 222.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 94.0
- Lexical Diversity: 1.59574
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14654176', '14532531', '13271118', '15343450', '15005948']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.827928004660565
- 35 USC 102 Novelty (BERT): 0.6681717790065652
- Combined Prediction Score: 0.8119523820951651
- Mean Citation Score: 627.1500920000002
- Max Citation Score: 746.3702
- Similarity Product: 635.8072239582061

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test